Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ubiquitin
-specific protease (USP)19 is a recently identified deubiquitinating enzyme (DUB) having multiple splice variants and cellular functions. One variant encodes an endoplasmic reticulum (ER)-anchored DUB that rescues misfolded transmembrane proteins from ER-associated degradation (ERAD), but the underlying mechanism remains to be elucidated. Here, we show that USP19 interacts with the ERAD-associated E3 ubiquitin ligase
MARCH6
. Overexpression of USP19 delayed the degradation of
MARCH6
, leading to an increase in its protein level. In contrast, USP19 depletion resulted in decreased expression of
MARCH6
. We also show that USP19 overexpression reduced ubiquitination of
MARCH6
, while its knockdown had the opposite effect. In particular, USP19 was found to protect
MARCH6
by deubiquitination from the p97-dependent proteasomal degradation. In addition, USP19 knockdown leads to increased expression of mutant ABCB11, an ERAD substrate of
MARCH6
. Moreover, USP19 is itself subjected to endoproteolytic processing by DUB activity, and the processing cleaves off an N-terminal cytoplasmic region of unknown function. However, elimination of this processing had no evident effect on
MARCH6
stabilization. These results suggest that USP19 is involved in the regulation of ERAD by controlling the stability of
MARCH6
via deubiquitination.
...
PMID:Ubiquitin-specific protease 19 regulates the stability of the E3 ubiquitin ligase MARCH6. 2508 57